Probi is a bioengineering company that identifies and, through clinical studies, documents the effects of various probiotic bacteria strains and patents them for use in foodstuffs and dietary supplements.
Probi’s patent protection is strong and encompasses both individual probiotic bacteria strains and the applications associated with them.
This entails that our strains and their applications can be protected and that we can license the rights for their use to other companies.
Probi’s current patent portfolio comprises 18 patent families (203 items), and 128 patents of which 51 protect the use of individual probiotic strains.
|Research areas||Indications||Number of patent families|
|The metabolic syndrome||Metabolic risk factors – Fibrinogen, cholesterol, blood pressure, insulin response||3|
|Nutrition/stress/recovery||Physiological stress – antioxidative capacity Iron uptake||3|